1[2]Vlahos CJ,Matter WF,Hui KY,et al.A specific inhibitor of phosphatidylinositol 3-kinase,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)[J].J Bio Chem,1994,269(7):5241-5248.
2[3]Brognard J,Clark AS,Ni YC,et al.Akt/Protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation[J].Cancer Res,2001,61 (15):3986-3997.
3[4]Liang J,Slingerland JM.Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression[J].Cell Cycle,2003,2(4):339-345.
4[5]Takeda A,Osaki M,Adachi K,et al.Role of the phosphatidylinositol 3′-kinase-Akt signal pathway in the proliferation of human pancreatic ductal carcinoma cell lines[J].Pancreas,2004,28(3):353-358.
5[6]Eugene SK,Jennifer S,Nathan M,et al.Activation of Akt/Protein Kinase B Overcomes a G2/M Cell Cycle Checkpoint Induced by DNA Damage[J].Mol Cell Biol,2002,22(22):7831-7841.
7Huisman MA, De Heer E, Grote JJ. Cholesteatoma epithelium is characterrized by increased expression of Ki-67, p53 and p21, with minimal apoptosis. Acta Otolaryngol, 2003, 123(3): 377-382.
8Kojima H, Shiwa M, Kamide Y, et al. Expression and localization of mRNA for epidermal growth factor and epidermal growth factor receptor in human cholesteatoma. Acta Otolaryngol, 1994, 114(4): 423-429.
9Ergun S, Zheng X, Carlsoo B. Expression of transforming growth factor-α and epidermal growth factor receptor in middle ear cholesteatoma. Am J Otol, 1996, 17(3): 393-396.
10Song G, Ouyang G, Bao S. The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med, 2005, 9(1): 59-71.
